Literature DB >> 28145948

Total Knee Arthroplasty After Anterior Cruciate Ligament Reconstruction: Not Just a Routine Primary Arthroplasty.

Tyler Steven Watters1, Yuan Zhen, J Ryan Martin, Daniel L Levy, Jason M Jennings, Douglas A Dennis.   

Abstract

BACKGROUND: Despite the success of restoring joint stability and improving early functional outcomes after anterior cruciate ligament (ACL) reconstruction, the long-term risk of developing symptomatic osteoarthritis requiring total knee arthroplasty is higher than that in the uninjured population. The purpose of this study was to compare operative characteristics and early outcomes of patients undergoing total knee arthroplasty after ACL reconstruction with those of a matched cohort of control subjects with primary osteoarthritis and no history of ligament reconstruction.
METHODS: All patients who had undergone total knee arthroplasty from 2005 to 2013 at our institution with a history of ACL reconstruction and a minimum 2-year follow-up were identified from a prospective research database. These patients were matched by demographic and surgeon variables to patients who had not undergone prior ACL reconstruction. Outcomes included Knee Society Scores (KSS), range of motion, operative variables, complications, and reoperations.
RESULTS: A cohort of 122 patients was identified as the ACL study group and was compared with the matched control cohort. The mean age at the time of the surgical procedure was 58 years, and 55% of the patients were male. The mean follow-up was 3.3 years in the ACL group and 3.0 years in the control group. There was no significant difference in the latest KSS outcomes between groups postoperatively (p > 0.05). Although preoperative flexion was significantly lower (p = 0.01) in the ACL group (119°) than in the control group (123°), there was no difference between groups postoperatively. Fifty percent (61 of 122) of patients in the ACL group required implant removal at the time of total knee arthroplasty. The operative time was significantly longer (p < 0.001) in the ACL group (88 minutes) compared with the control group (73 minutes). There were a total of 11 reoperations in the ACL group, including 4 for periprosthetic infection, whereas there were only 2 reoperations in the control group. The risk of reoperation in the ACL group was more than 5 times higher than in the control group (relative risk, 5.5 [95% confidence interval, 1.2 to 24.3]; p = 0.01).
CONCLUSIONS: The results of this retrospective matched cohort study suggest that prior ACL reconstruction results in longer operative time and increased risk of early reoperation after total knee arthroplasty. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2017        PMID: 28145948     DOI: 10.2106/JBJS.16.00524

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  4 in total

Review 1.  Does Prior Anterior Cruciate Ligament Reconstruction Affect Outcomes of Subsequent Total Knee Arthroplasty? A Systematic Review.

Authors:  Zaira S Chaudhry; Hytham S Salem; James J Purtill; Sommer Hammoud
Journal:  Orthop J Sports Med       Date:  2019-07-12

2.  The influence of previous arthroscopic treatment on subsequent primary total knee arthroplasty: the comparison between bilateral knees of the same patient.

Authors:  Kuishuai Xu; Liang Zhang; Rui Shen; Cailin Wang; Tianyu Li; Xia Zhao; Tengbo Yu
Journal:  BMC Musculoskelet Disord       Date:  2021-01-29       Impact factor: 2.362

3.  When can total knee arthroplasty be safely performed following prior arthroscopy?

Authors:  Jin-Ning Ma; Xiao-Lin Li; Pan Liang; Sheng-Li Yu
Journal:  BMC Musculoskelet Disord       Date:  2021-01-04       Impact factor: 2.362

4.  Anterior cruciate ligament deficiency versus intactness for outcomes in patients after unicompartmental knee arthroplasty: a systematic review and meta-analysis.

Authors:  Weiming Guo; Teng Wan; Haifeng Tan; Gang Fan; Xiaoyu Gao; Pan Liu; Changqing Jiang
Journal:  Front Bioeng Biotechnol       Date:  2022-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.